What's new

Human medicines European public assessment report (EPAR): Zelboraf, vemurafenib, Date of authorisation: 17/02/2012, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR): Zelboraf, vemurafenib, Date of authorisation: 17/02/2012, Revision: 26, Status: Authorised

Jun 19, 2025 - 13:45
 0
Human medicines European public assessment report (EPAR): Zelboraf, vemurafenib, Date of authorisation: 17/02/2012, Revision: 26, Status: Authorised
Human medicines European public assessment report (EPAR): Zelboraf, vemurafenib, Date of authorisation: 17/02/2012, Revision: 26, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Lupkynis, voclosporin,...

Next Article

Outcome of written procedures finalised during the period from 4 March 2025 to 2...

Related Posts

Human medicines European public assessment report (EPAR): Zabdeno, ebola vaccine (Ad26.ZEBOV-GP [recombinant]), Date of authorisation: 01/07/2020, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

May 14, 2025  0

Concept paper on the new reflection paper on the clinic...

Jun 18, 2025  0

Human medicines European public assessment report (EPAR): Levetiracetam Hospira, levetiracetam, Date of authorisation: 07/01/2014, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR...

May 12, 2025  0